Versalock Rib and Sternum Plates System
Device Facts
| Record ID | K232829 |
|---|---|
| Device Name | Versalock Rib and Sternum Plates System |
| Applicant | GM Dos Reis Industria e Comercio Ltda. |
| Product Code | HRS · Orthopedic |
| Decision Date | Jun 26, 2024 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 888.3030 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
The Versalock Rib and Sternum Plates System is intended for use in the stabilization and fixation of fractures of the anterior chest wall including sternal fixation following sternal reconstructive surgical procedures, rib and sternum fractures, fusions and osteotomies.
Device Story
The Versalock Rib and Sternum Plates System provides rigid bone fixation for chest wall fractures and sternal reconstruction. The system consists of metallic plates and screws; screws feature a specific thread profile allowing for a variable angle of ±15° within the plate's threaded holes, though non-threaded head screws may also be used. The device is intended for use by surgeons in clinical settings. By providing stable fixation, the system facilitates bone healing and structural integrity of the chest wall following trauma or surgical procedures.
Clinical Evidence
No clinical data were included in this submission. Performance was demonstrated through bench testing, including torsional properties, driving torque, axial pullout strength (ASTM F543), static/fatigue bending (ASTM F382), and lateral/longitudinal/transversal shear testing. Pyrogen testing was conducted per USP <151>.
Technological Characteristics
Materials: Titanium Alloy (ASTM F136) and Pure Titanium (ASTM F67). Design: Metallic bone plates and screws with variable angle (±15°) fixation capability. Sterilization: Ethylene Oxide (sterile) or steam sterilization (non-sterile).
Indications for Use
Indicated for patients requiring stabilization and fixation of anterior chest wall fractures, including sternal fixation post-sternotomy, sternal reconstructive procedures, rib/sternum fractures, fusions, and osteotomies.
Regulatory Classification
Identification
Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.
Predicate Devices
Reference Devices
- Mini and Micro Fragments Reconstruction System (K182718)
- Suture Anchors - HTA Headless Titanium Anchor and Zip Anchors (K223114)
- KLS Martin Thoracic Plating System (K153482)
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
June 26, 2024
GM Dos Reis Industria e Comercio Ltda Guilherme Esteves Pontes Regulatory Affairs Analyst Avenida Pierre Simon de La Place 600 Campinas, SP 13069-320 Brazil
Re: K232829
Trade/Device Name: Versalock Rib and Sternum Plates System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: April 17, 2024 Received: April 17, 2024
Dear Guilherme Esteves Pontes:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"
{1}------------------------------------------------
### K232829 - Guilherme Esteves Pontes
(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100. Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Shumaya Ali-S
Shumaya Ali, M.P.H.
Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
{2}------------------------------------------------
# Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below.
Submission Number (if known)
K232829
Device Name
Versalock Rib and Sternum Plates System
Indications for Use (Describe)
The Versalock Rib and Sternum Plates System is intended for use in the stabilization and fixation of fractures of the anterior chest wall including sternal fixation following sternal reconstructive surgical procedures, rib and sternum fractures, fusions and osteotomies.
Type of Use (Select one or both, as applicable)
> Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image contains the logo for "GMREIS Qualidade para Vida". The logo consists of a circular graphic on the left, with a blue lower half and a red upper portion, accompanied by the text "GMREIS" in a bold, blue font. Below the company name, the phrase "Qualidade para Vida" is written in a smaller, lighter blue font.
## 510(k) Summary
This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of 21 CFR §807.92.
### I. Submitter:
GM Dos Reis Industria e Comercio Ltda Avenida Pierre Simon de La Place 600. Campinas. São Paulo, Brazil 13069-320 Guilherme Esteves Pontes, Regulatory Affairs Analyst Telephone: +55 (19) 3765-9900, email: guilherme.qualidade@gmreis.com.br Date prepared: June 26, 2024.
### II. Device Name:
| Trade Name: | Versalock Rib and Sternum Plates System |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------|
| Common Name: | Plate, Fixation, Bone / Screw, Fixation, Bone |
| Classification Name: | Single/multiple component metallic bone fixation<br>appliances and accessories / Smooth or threaded metallic<br>bone fixation fastener |
| Device Class: | II |
| Product Codes: | HRS, HWC |
| Regulation Number: | 21 CFR 888.3030, 888.3040 |
### III. Predicate Devices:
Legally marketed devices to which we are claiming "Substantial Equivalence" are the following:
MatrixRIB Fixation System (K161590) (Primary predicate device). Biomet Microfixation Sternal Closure System (K161896) (Additional predicate device). Mini and Micro Fragments Reconstruction System (K182718) (Reference device).
{4}------------------------------------------------
2
Image /page/4/Picture/1 description: The image is a logo for GMREIS. The logo consists of a circular graphic on the left and the text "GMREIS" on the right. Below the text is the phrase "Qualidade para Vida". The circular graphic is blue and red, with a white outline.
Suture Anchors - HTA Headless Titanium Anchor and Zip Anchors (K223114) (Reference device)
KLS Martin Thoracic Plating System (K153482) (Reference device).
### IV. Device Description:
The Versalock Rib and Sternum Plates System is indicated for the stabilization and rigid fixation of chest wall fractures, including sternal reconstruction processes, trauma and/or planned osteotomies. The physical principle is based on rigid fixation, where the screws have a specific thread profile in their head, which, when fixed, allows the surgeon to fix it with a variable angle of ±15° in the threaded hole of the plate. The system also allows fixation with non-threaded head screws when the surgeon so desires. The devices are presented in Titanium Alloy according to the standard ASTM F136 and Pure Titanium According to ASTM F67.
# V. Statement of Indications for Use of the Device:
The Versalock Rib and Sternum Plates System is intended for use in the stabilization and fixation of fractures of the anterior chest wall including sternal fixation following sternotomy, sternal reconstructive surgical procedures, rib and sternum fractures, fusions and osteotomies.
### VI. Comparison of Technological Characteristics with The Predicate Device:
The subject device is substantially equivalent in indications and design principles to the following predicate devices:
K161590 - MatrixRIB Fixation System - DePuy Synthes
K161896 - Biomet Microfixation Sternal Closure System - Biomet Microfixation The subject and predicate devices have equivalent intended use and equivalent technological characteristics. The subject and predicate devices are all manufactured from identical materials and share equivalent design characteristics. The subject and predicate devices encompass equivalent physical dimensions. Any difference in the technological
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the logo for GMREIS. The logo consists of a circular graphic on the left, with a blue lower half and a red upper portion. To the right of the graphic is the text "GMREIS" in a bold, blue font. Below the company name is the text "Qualidade para Vida" in a smaller, lighter blue font.
characteristics do not raise new issues of safety or efficacy. The performance of the subject devices was compared with the predicates and are demonstrated through mechanical testing according to ASTM F543 and ASTM F382. No clinical data were included in this submission. The subject devices could be provided in sterile condition sterilized by Ethylene Oxide or non-sterile condition to end user, the non-sterile version must be cleaned, and steam sterilized before use. Pyrogen test according to USP <151> was conducted to demonstrate that the device meets pyrogen limit specifications.
### VII. Performance Data:
The non-clinical tests performed and the Recognized Consensus Standards to which the Versalock Rib and Sternum Plates System have been tested are specifically the following:
- . Torsional Properties of Metallic Bone Screws per ASTM F543
- Driving Torque of Medical Bone Screws per ASTM F543 .
- Axial Pullout Strength of Medical Bone Screws per ASTM F543 ●
- Single Cycle Bending Test (Static) per ASTM F382
- Bending Fatigue Test per ASTM F382 ●
- Lateral Distraction, Longitudinal and Transversal Shear .
### VIII. Conclusions:
As was established in this submission, the subject Versalock Rib and Sternum Plates System are substantially equivalent to the predicate devices cleared by the FDA for commercial distribution in the United States. The subject device was shown to be substantially equivalent and have the same technological characteristics, intended use, indications for use, material composition, anatomical region, multiple sizes, and basic design features compared to its predicate devices. Any differences between the Versalock Rib and Sternum Plates System and the predicate devices are considered minor and do not raise different questions of safety or effectiveness.
